The role of PRDM1 in epigenetic regulation and tumor suppression

Oliver W Press

Pretargeted Radioimmunotherapy of CD20+ Lymphomas

Non-Hodgkin lymphoma

Hematology and hematologic malignancies Radiation Oncology Pathology

Daniel McVicar

Characterization of the Expression and Ligands of KIR3DS2

Leukaemia

Pathology Hematology and hematologic malignancies

Luca Gattinoni

Programming T Cell Fates for Therapeutic Use

Leukaemia

Pathology Hematology and hematologic malignancies

Derrick J. Rossi

Reprogramming committed blood cells to a hematopoietic stem cell fate

Leukaemia

Hematology and hematologic malignancies

Julie Aurore Losman

The Role of EglN1 and HIF in Normal Hematopoiesis and in Leukemia

Leukaemia

Catherine Ju-Ying Wu

(PQD1) Impact of Cytotoxic and Targeted Therapy on Clonal Evolution of CLL

Leukaemia

Hematology and hematologic malignancies Pathology

Seth J Corey

Genetic Modifiers for Cancer Stem Cells in Secondary MDS/AML

Leukaemia

Pediatric oncology or childhood cancer Hematology and hematologic malignancies

David A Williams

Rac proteins in hematopoietic cell survival and function

Leukaemia

Hematology and hematologic malignancies

S Diane Hayward

Herpesvirus Protein Kinases: Substrate Recognition and Pathway Targeting

Hodgkin lymphoma

Pathology